BofA lowered the firm’s price target on Amdocs (DOX) to $78 from $97 and keeps a Buy rating on the shares. While the firm remains positive on underlying trends after a “robust quarter,” it lowers its price target to account for peer group multiple compression, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOX:
- Amdocs price target lowered to $71 from $88 at Stifel
- Amdocs Posts Solid Q2 2026 Results and Names New CFO as It Pushes Into ‘Agentic’ Telco Era
- Amdocs enters multi-year agreement with Telefonica Moviles Argentina
- Amdocs reports Q2 EPS $1.78, consensus $1.76
- Amdocs sees Q3 EPS $1.81-$1.87, consensus $1.89